Form 8.3 - [Allergan Plc]
December 23 2019 - 10:02AM
Dow Jones News
TIDM0Y7T TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Allergan plc
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.0001 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 20(th) December 2019
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 14,777,608 4.49966%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 14,777,608 4.49966%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 100 190.30
-------------- ----------------------------- -----------------------
Purchase 2,600 190.35
-------------- ----------------------------- -----------------------
Purchase 1,649 190.30
-------------- ----------------------------- -----------------------
Purchase 100 190.30
-------------- ----------------------------- -----------------------
Purchase 2,500 190.35
-------------- ----------------------------- -----------------------
Purchase 100 191.41
-------------- ----------------------------- -----------------------
Purchase 100 190.30
-------------- ----------------------------- -----------------------
Purchase 3,000 190.35
-------------- ----------------------------- -----------------------
Purchase 100 190.30
-------------- ----------------------------- -----------------------
Purchase 3,000 190.35
-------------- ----------------------------- -----------------------
Purchase 200 190.66
-------------- ----------------------------- -----------------------
Purchase 2,700 190.66
-------------- ----------------------------- -----------------------
Purchase 1,972 190.30
-------------- ----------------------------- -----------------------
Purchase 63 190.35
-------------- ----------------------------- -----------------------
Purchase 133,650 190.30
-------------- ----------------------------- -----------------------
Purchase 3,960 190.30
-------------- ----------------------------- -----------------------
Purchase 3,987 190.30
-------------- ----------------------------- -----------------------
Purchase 2,484 190.30
-------------- ----------------------------- -----------------------
Purchase 1,900 190.35
-------------- ----------------------------- -----------------------
Purchase 60 191.46
-------------- ----------------------------- -----------------------
Purchase 40 190.30
-------------- ----------------------------- -----------------------
Purchase 88 190.30
-------------- ----------------------------- -----------------------
Purchase 2,728 190.30
-------------- ----------------------------- -----------------------
Purchase 200 190.35
-------------- ----------------------------- -----------------------
Sale 1,300 190.75
-------------- ----------------------------- -----------------------
Sale 93 190.30
-------------- ----------------------------- -----------------------
Sale 100 190.30
-------------- ----------------------------- -----------------------
Sale 100 190.30
-------------- ----------------------------- -----------------------
Sale 100 190.30
-------------- ----------------------------- -----------------------
Sale 100 190.30
-------------- ----------------------------- -----------------------
Sale 33,800 190.30
-------------- ----------------------------- -----------------------
Sale 659 190.30
-------------- ----------------------------- -----------------------
Sale 3,493 190.30
-------------- ----------------------------- -----------------------
Sale 59 190.30
-------------- ----------------------------- -----------------------
Sale 59 190.30
-------------- ----------------------------- -----------------------
Sale 4 190.30
-------------- ----------------------------- -----------------------
Sale 25 191.76
-------------- ----------------------------- -----------------------
Sale 232,816 190.88
-------------- ----------------------------- -----------------------
Sale 4,784 191.70
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- --------------------
Date of disclosure 23(rd) December 2019
------------------------------------------------------- --------------------
Contact name Colin Fernandes
------------------------------------------------------- --------------------
Telephone number 020 33956221
------------------------------------------------------- --------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- --------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- --------------------
(END) Dow Jones Newswires
December 23, 2019 09:47 ET (14:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024
